ReviewCNS drugs2018
Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010.
Simon Faissner et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
42 papers cite it
this paperpooled ittrialcites it
ReviewCNS drugs2018
Simon Faissner et al.PubMed ↗Publisher ↗
No numbers read from the abstract.